8 Einträge gefunden

1. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Kühn, Michael W M
   6. Schroeder, Thomas
   7. Mayer, Karin

   2023 - Forschungsinformationssystem des UKE
2. Midostaurin plus intensive chemotherapy for younger and older Patients with AML and FLT3 internal tandem duplications

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Wulf, Gerald Georg
   6. Salih, Helmut R
   7. Lübbert, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

   1. Döhner, Hartmut
   2. Müller-Tidow, Carsten
   3. Lübbert, Michael
   4. Fiedler, Walter
   5. Krämer, Alwin
   6. Westermann, Jörg
   7. Bug, Gesine

   2019 - Forschungsinformationssystem des UKE
4. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

   1. Schlenk, Richard F
   2. Weber, Daniela
   3. Fiedler, Walter
   4. Salih, Helmut R
   5. Wulf, Gerald
   6. Salwender, Hans
   7. Schroeder, Thomas

   2019 - Forschungsinformationssystem des UKE
5. Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

   1. Krauter, Jürgen
   2. Fiedler, Walter
   3. Schlenk, Richard F
   4. Paschka, Peter
   5. Thol, Felicitas
   6. Lübbert, Michael
   7. Wattad, Mohammed

   2018 - Forschungsinformationssystem des UKE
6. Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

   1. Döhner, Hartmut
   2. Lübbert, Michael
   3. Fiedler, Walter
   4. Fouillard, Loic
   5. Haaland, Alf
   6. Brandwein, Joseph M
   7. Lepretre, Stephane

   2014 - Forschungsinformationssystem des UKE
7. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.

   1. Thol, Felicitas
   2. Winschel, Claudia
   3. Sonntag, Ann-Kathrin
   4. Damm, Frederik
   5. Wagner, Katharina
   6. Chaturvedi, Anuhar
   7. Göhring, Gudrun

   2013 - Forschungsinformationssystem des UKE
8. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype.

   1. Damm, Frederik
   2. Heuser, Michael
   3. Morgan, Michael
   4. Wagner, Katharina
   5. Görlich, Kerstin
   6. Grosshennig, Anika
   7. Hamwi, Iyas

   2011 - Forschungsinformationssystem des UKE